Regulation of Mitochondrial Oxidative Metabolism by Tumor Suppressor FLCN

Abstract

FLCN deficiency and subsequent increased PPARGC1A expression result in increased mitochondrial function and oxidative metabolism as the source of cellular energy, which may give FLCN-null kidney cells a growth advantage and drive hyperplastic transformation.